From the beginning, Imspex Diagnostic’s ambition has been to bring the unique advantages of GC-IMS technology to patients. Our aim has always been to give patients the best possible chance to beat disease conditions by detecting and diagnosing these as early as possible.

Our journey to being able to do so is continuing apace. A combination of dedicated
commercial infrastructure and analytical resource is now in place in the form of the Imspex
Medical division of the ImspexGroup. With patented technology and data being validated
with partners globally, we are well positioned to be able to bring rapid, robust, reliable and
ultrasensitive detection capability to patients at point-of-need for our first disease targets
of respiratory tract infections and COVID-19.

Watch this space for the next steps in our story.